dipyridamole and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

dipyridamole has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arisaka, O; Kano, K; Nishikura, K; Yamada, Y	1
Csanády, M; Forster, T; Gruber, N; Nemes, A; Neu, K	1
Chen, EX; Fleshner, NE; Hamilton, RJ; Longo, J; Masoomian, M; Mullen, PJ; Penn, LZ; Sweet, JM; van der Kwast, TH; van Leeuwen, JE; Wang, Y; Woon, DTS; Yu, R	1

Trials

1 trial(s) available for dipyridamole and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria. Clinical nephrology, 2003, Volume: 60, Issue:2 Topics: Adolescent; Child; Dipyridamole; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glomerulonephritis, IGA; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney; Male; Prospective Studies; Proteinuria; Vasodilator Agents	2003

Article

Year

Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.

Clinical nephrology, 2003, Volume: 60, Issue:2

Topics: Adolescent; Child; Dipyridamole; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glomerulonephritis, IGA; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney; Male; Prospective Studies; Proteinuria; Vasodilator Agents

2003

Other Studies

2 other study(ies) available for dipyridamole and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram. Echocardiography (Mount Kisco, N.Y.), 2004, Volume: 21, Issue:1 Topics: Adult; Aged; Anticholesteremic Agents; Blood Flow Velocity; Cholesterol; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Stress; Echocardiography, Transesophageal; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Vasodilator Agents	2004
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer. Molecular metabolism, 2019, Volume: 25 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dipyridamole; Drug Repositioning; Fluvastatin; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Mevalonic Acid; Mice; Mice, Inbred NOD; Mice, SCID; Prostatic Neoplasms; Sterol Regulatory Element Binding Protein 2; Sterols; Xenograft Model Antitumor Assays	2019

Article

Year

Relationship between hypercholesterolemia, lipid-lowering therapy and coronary flow velocity reserve evaluated by stress transesophageal echocardiography in patients with a negative coronary angiogram.

Echocardiography (Mount Kisco, N.Y.), 2004, Volume: 21, Issue:1

Topics: Adult; Aged; Anticholesteremic Agents; Blood Flow Velocity; Cholesterol; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Stress; Echocardiography, Transesophageal; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Vasodilator Agents

2004

An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.

Molecular metabolism, 2019, Volume: 25

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dipyridamole; Drug Repositioning; Fluvastatin; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Male; Mevalonic Acid; Mice; Mice, Inbred NOD; Mice, SCID; Prostatic Neoplasms; Sterol Regulatory Element Binding Protein 2; Sterols; Xenograft Model Antitumor Assays

2019